Cargando…

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Detalles Bibliográficos
Autores principales:	Martikainen, Jaana E, Maljanen, Timo, Koskinen, Hanna, Vogler, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603335/ http://dx.doi.org/10.1186/2052-3211-8-S1-P2

Ejemplares similares

The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland
por: Koskinen, Hanna, et al.
Publicado: (2014)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018)

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
por: Spillane, Susan, et al.
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Price dispersion of generic medications
por: Bernstein, John J. J., et al.
Publicado: (2019)

Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
por: Vogler, Sabine, et al.
Publicado: (2019)

Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012)

Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation
por: Vogler, Sabine, et al.
Publicado: (2020)

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Overview of external reference pricing systems in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2015)

Development of pharmaceutical prices in the Republic of Macedonia in comparison to selected countries outside the national reference baskets
por: Hristova, Kristina, et al.
Publicado: (2015)

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
por: Drummond, Michael, et al.
Publicado: (2010)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

Developing a Drug Price Reference Index in the Philippines
por: Haasis, Manuel A, et al.
Publicado: (2015)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland
por: Luukkanen, Saana V., et al.
Publicado: (2022)

A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators
por: Hu, Shanlian, et al.
Publicado: (2015)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
por: Moreno, Santiago G., et al.
Publicado: (2019)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Influence of generic reference pricing on medicine cost in Slovenia: a retrospective study
por: Marđetko, Nika, et al.
Publicado: (2018)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Price indexes for pharmaceuticals used by the elderly
por: Thomas, Joseph, et al.
Publicado: (1992)

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

The Short-Term Impact of Ontario's Generic Pricing Reforms
por: Law, Michael R., et al.
Publicado: (2011)

Upstream solutions for price-gouging on critical generic medicines
por: Houston, Adam R., et al.
Publicado: (2016)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
por: Zhang, Wei, et al.
Publicado: (2020)

Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?
por: Son, Kyung-Bok
Publicado: (2022)

Interindustry linkages of prices—Analysis of Japan’s deflation
por: Kichikawa, Yuichi, et al.
Publicado: (2020)

Public finance and the price system
por: Browning, Edgar K, et al.
Publicado: (1979)

Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
por: Atikeler, Enver Kagan, et al.
Publicado: (2016)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019)

Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment
por: Hollin, Ilene L., et al.
Publicado: (2022)

International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
por: Sullivan, Sean D, et al.
Publicado: (2022)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2a1c77uau1omj66u3a490dq5oi